What You Should Know: - VieCure, a leading cancer care company, announced today that it's integrating DrFirst's e-prescribing and medication management solutions into its clinical decision support system. - VieCure is a well-established point-of-care intelligence system specifically designed for community oncologists. Utilizing artificial intelligence (AI), patient data, and a comprehensive oncology knowledge base, VieCure generates personalized treatment plans for cancer
Read More
Cancer Diagnostics
Culmination Bio, BillionToOne Partner to Validate Cancer Diagnostics
What You Should Know: Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.Culmination Bio and BillionToOne are working together to leverage their respective strengths in order to facilitate the development and validation of robust and impactful oncology
Read More
American Cancer Society, Color Health Expand Cancer Care Program for Employers and Unions
What You Should Know: - The American Cancer Society (ACS) and Color Health announced today a significant expansion of their existing program, creating a first-of-its-kind comprehensive cancer solution for employers and labor unions. This enhanced program goes beyond screening and prevention to support employees and members throughout all stages of the cancer journey. - The expanded program builds upon the existing collaboration between ACS and Color Health, which has already provided
Read More
Lunit Expands AI-powered Cancer Screening Solution to France and Portugal
What You Should Know: - Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion. - These strategic deals will bring Lunit's AI-powered cancer screening solution to healthcare providers in France and Portugal, aiding in the fight against cancer. TeleDiag and Lunit Partner to Improve Lung Cancer Detection in France Lunit has partnered with TeleDiag,
Read More
6 Ways AI is Impacting Cancer Diagnosis, Treatment and Patient Outcomes in 2024
Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how X-rays and genetic tests revolutionized healthcare in the past. Reshaping routine diagnostic procedures and treatment decisions and propelling pharmaceutical and research domains into new realms, AI offers significant benefits to clinicians, healthcare systems, researchers, and, most importantly, patients. This is particularly evident in cancer diagnosis and treatment across six key areas: 1.
Read More
Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer
What You Should Know: - Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer. - This partnership combines Absci's cutting-edge Integrated Drug Creation™ platform with AstraZeneca's oncology expertise, aiming to accelerate the discovery of a potential new cancer treatment. Absci's AI Engine Takes the Lead Absci will leverage
Read More
Ibex Medical Analytics Raises $55M to Drive AI for Cancer Diagnosis Adoption Globally
What You Should Know: – Ibex Medical Analytics (Ibex), a provider of AI-powered cancer diagnostics raises $55M in Series C financing round led by 83North. - The round also included participation from Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100M since Ibex’s inception in 2016.
Read More
Ibex’s AI-Powered Cancer Diagnostics Solution Obtains CE Mark
What You Should Know: - Ibex Medical Analytics today announced that Galen™ Prostate has become the first standalone AI-powered cancer diagnostics solution to obtain CE Mark under Vitro Diagnostic Medical Devices Regulation (IVDR) for supporting pathologists in the primary diagnosis of prostate biopsies. - Galen Prostate is the first standalone AI-based cancer diagnostics product of its kind certified under the IVDR. - During 2023, Ibex plans to migrate additional
Read More
Liver Cancer Awareness – Here’s What You Need to Know in 2023
By the end of 2022, nearly 42,00 new cases of primary liver cancer will be diagnosed in the United States. In fact, liver cancer incidence rates have more than tripled since 1980, marking an increased need for better detection and diagnosis. We might not talk about liver cancer as much as we do breast or lung cancer, but it’s a real threat to millions of Americans – and we need to continue spreading awareness. Early detection is especially critical in treating liver cancer.
Read More
Intelerad Acquires PenRad Technologies
What You Should Know: - Today, Intelerad, a leading global provider of enterprise medical imaging solutions, announced its acquisition of PenRad, a software provider for enhancing productivity for breast imaging and lung screening. - The acquisition expands Intelerad’s product offerings for mammography and lung analytics, ensuring radiologists, technologists and other healthcare professionals can drive greater productivity and meet higher oncology screening demand, while improving patient
Read More
